Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Guido Tricot

Concepts (548)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
147
2024
2990
9.030
Why?
Hematopoietic Stem Cell Transplantation
28
2024
580
3.580
Why?
Pyrazines
20
2023
187
2.630
Why?
Antineoplastic Combined Chemotherapy Protocols
35
2024
997
2.490
Why?
Boronic Acids
19
2014
182
2.430
Why?
Thalidomide
28
2023
375
2.410
Why?
Antineoplastic Agents
30
2020
1165
1.950
Why?
Transplantation, Autologous
30
2024
480
1.930
Why?
Drug Resistance, Neoplasm
17
2020
315
1.450
Why?
Transplantation Conditioning
9
2019
88
1.450
Why?
Paraproteinemias
8
2018
71
1.270
Why?
Humans
157
2024
50419
1.190
Why?
Neoplastic Stem Cells
5
2020
97
1.170
Why?
Protease Inhibitors
6
2011
58
1.060
Why?
Venous Thrombosis
7
2009
86
1.030
Why?
Melphalan
16
2023
177
0.990
Why?
Stem Cell Transplantation
13
2023
179
0.990
Why?
Angiogenesis Inhibitors
9
2009
183
0.980
Why?
Aged
58
2024
9738
0.940
Why?
Gene Expression Regulation, Neoplastic
13
2020
831
0.930
Why?
Hematopoietic Stem Cell Mobilization
5
2014
58
0.930
Why?
Prognosis
33
2024
1974
0.910
Why?
Middle Aged
60
2024
12579
0.880
Why?
Alkaline Phosphatase
5
2011
94
0.840
Why?
Busulfan
3
2019
19
0.830
Why?
Treatment Outcome
39
2022
5265
0.780
Why?
Plasma Cells
11
2023
220
0.770
Why?
Dexamethasone
16
2024
431
0.740
Why?
Male
68
2024
25866
0.700
Why?
Chromosome Aberrations
9
2008
279
0.660
Why?
Female
64
2024
27053
0.650
Why?
Thromboembolism
3
2009
54
0.650
Why?
Neoplasm Proteins
6
2021
320
0.620
Why?
Chromosomes, Human, Pair 13
6
2008
34
0.600
Why?
Disease-Free Survival
14
2019
439
0.570
Why?
Immunoglobulin Light Chains
3
2016
83
0.560
Why?
Survival Rate
18
2019
906
0.560
Why?
Bone Remodeling
2
2010
148
0.560
Why?
Anticoagulants
5
2009
254
0.560
Why?
Gene Expression Profiling
18
2023
1020
0.550
Why?
Blood Transfusion
1
2018
123
0.550
Why?
Immunologic Factors
5
2012
113
0.540
Why?
Cell Line, Tumor
18
2023
1393
0.520
Why?
Follow-Up Studies
21
2024
2231
0.510
Why?
Receptors, Retinoic Acid
2
2013
22
0.500
Why?
Antineoplastic Agents, Alkylating
7
2008
73
0.500
Why?
Proteasome Inhibitors
6
2018
104
0.490
Why?
IMP Dehydrogenase
2
2006
3
0.490
Why?
Mycophenolic Acid
2
2006
18
0.490
Why?
Adult
38
2024
13561
0.480
Why?
Clinical Trials as Topic
9
2022
488
0.480
Why?
Combined Modality Therapy
13
2008
640
0.470
Why?
Cell Proliferation
15
2020
980
0.470
Why?
Recurrence
16
2018
657
0.470
Why?
Antigens, Neoplasm
5
2007
148
0.450
Why?
Apoptosis
9
2019
1092
0.450
Why?
Up-Regulation
5
2020
446
0.450
Why?
Antibodies, Monoclonal
3
2015
460
0.450
Why?
Animals
30
2024
13063
0.440
Why?
Osteogenesis
3
2012
354
0.440
Why?
Retrospective Studies
18
2024
6274
0.440
Why?
Venous Thromboembolism
3
2011
74
0.430
Why?
Survival Analysis
12
2021
658
0.430
Why?
Signal Transduction
12
2020
1608
0.420
Why?
Disease Progression
12
2019
825
0.420
Why?
Doxorubicin
8
2018
235
0.420
Why?
Bone Diseases
3
2012
96
0.410
Why?
Neoplasms, Second Primary
2
2024
74
0.400
Why?
Thrombosis
4
2012
250
0.400
Why?
Central Nervous System Neoplasms
2
2004
61
0.390
Why?
T-Lymphocytes
10
2024
325
0.390
Why?
Myeloablative Agonists
5
2014
32
0.380
Why?
Bone Marrow
7
2022
360
0.380
Why?
Transplantation, Homologous
6
2004
146
0.370
Why?
Oligopeptides
2
2013
94
0.370
Why?
Osteoblasts
4
2007
463
0.370
Why?
Risk Factors
18
2018
3712
0.370
Why?
Hematopoietic Stem Cells
2
2010
197
0.360
Why?
Tumor Microenvironment
3
2024
221
0.350
Why?
Meta-Analysis as Topic
2
2015
38
0.350
Why?
Granulocyte Colony-Stimulating Factor
2
2008
63
0.350
Why?
Salvage Therapy
9
2012
137
0.350
Why?
Mice
19
2024
5659
0.350
Why?
Bone Marrow Transplantation
5
2007
135
0.340
Why?
Enzyme Inhibitors
2
2019
369
0.340
Why?
Membrane Proteins
4
2017
337
0.340
Why?
Monoclonal Gammopathy of Undetermined Significance
4
2024
112
0.330
Why?
Ultrasonography, Doppler
2
2007
41
0.330
Why?
Remission Induction
10
2008
208
0.330
Why?
Prospective Studies
9
2019
2378
0.320
Why?
Cell Cycle Proteins
2
2021
163
0.320
Why?
Neoplasm, Residual
4
2022
161
0.320
Why?
Myelodysplastic Syndromes
4
2007
78
0.320
Why?
B-Lymphocytes
4
2021
171
0.310
Why?
Waldenstrom Macroglobulinemia
3
2018
40
0.310
Why?
Lymphoma, B-Cell
3
2021
49
0.310
Why?
Immunosuppressive Agents
3
2005
227
0.300
Why?
Neovascularization, Pathologic
1
2009
155
0.300
Why?
Bone Neoplasms
1
2010
178
0.300
Why?
Killer Cells, Natural
4
2024
107
0.290
Why?
Brain Diseases, Metabolic
1
2007
4
0.280
Why?
Proteasome Endopeptidase Complex
4
2018
116
0.280
Why?
Aged, 80 and over
11
2019
3233
0.280
Why?
Chromosome Deletion
3
2008
134
0.280
Why?
Dose-Response Relationship, Drug
6
2016
1369
0.280
Why?
Hyperammonemia
1
2007
22
0.280
Why?
Amyloidosis
2
2007
79
0.270
Why?
Research Design
1
2009
348
0.270
Why?
Farnesyltranstransferase
1
2006
5
0.270
Why?
Thrombophilia
4
2009
18
0.270
Why?
Small Molecule Libraries
2
2019
67
0.270
Why?
Peripheral Blood Stem Cell Transplantation
4
2014
56
0.270
Why?
Hemostasis
1
2007
59
0.270
Why?
Bone and Bones
1
2010
481
0.260
Why?
Sirolimus
1
2006
61
0.260
Why?
Immunotherapy, Adoptive
4
2024
161
0.250
Why?
Cell Survival
8
2018
587
0.250
Why?
Gastrointestinal Neoplasms
1
2006
40
0.250
Why?
In Situ Hybridization, Fluorescence
6
2016
231
0.250
Why?
Caspases
1
2006
103
0.240
Why?
Flow Cytometry
6
2018
472
0.240
Why?
Diploidy
2
2004
26
0.240
Why?
beta 2-Microglobulin
5
2008
37
0.240
Why?
Antibody Formation
1
2005
50
0.230
Why?
Religion
1
2005
62
0.230
Why?
Activated Protein C Resistance
4
2011
10
0.230
Why?
Case-Control Studies
10
2018
1152
0.230
Why?
Aneuploidy
1
2004
18
0.230
Why?
Enoxaparin
1
2004
31
0.230
Why?
Attitude to Health
1
2005
190
0.220
Why?
Ubiquitination
2
2021
42
0.220
Why?
Adaptation, Psychological
1
2005
224
0.220
Why?
Osteolysis
2
2022
74
0.210
Why?
Multivariate Analysis
5
2008
583
0.210
Why?
Cancer Vaccines
3
2010
80
0.210
Why?
Cisplatin
6
2009
283
0.210
Why?
Randomized Controlled Trials as Topic
4
2012
567
0.210
Why?
Pyrimidines
3
2015
187
0.210
Why?
Cell Communication
2
2006
70
0.210
Why?
Blood Coagulation
1
2003
59
0.200
Why?
Mice, Inbred NOD
6
2020
89
0.200
Why?
Antigens, CD34
1
2003
75
0.200
Why?
Critical Illness
1
2005
302
0.200
Why?
Cytogenetic Analysis
6
2007
74
0.200
Why?
Graft vs Host Disease
5
2010
85
0.200
Why?
Parathyroid Hormone
3
2010
149
0.200
Why?
STAT3 Transcription Factor
4
2015
77
0.190
Why?
Cyclophosphamide
4
2003
168
0.190
Why?
Leukemia, Myeloid
1
2002
44
0.190
Why?
Kidney
1
2007
690
0.190
Why?
Bone Resorption
2
2022
301
0.190
Why?
Chromosome Disorders
1
2002
33
0.190
Why?
Time Factors
9
2016
2933
0.190
Why?
Etoposide
5
2009
77
0.190
Why?
Logistic Models
5
2018
901
0.180
Why?
Hypothyroidism
1
2002
56
0.180
Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2015
68
0.180
Why?
Chromosomes, Human, Pair 1
3
2006
92
0.180
Why?
Antibodies, Bispecific
1
2022
88
0.180
Why?
Neoplasm Recurrence, Local
4
2024
622
0.170
Why?
Neoplasms
2
2009
1248
0.170
Why?
Cytotoxicity, Immunologic
3
2012
57
0.170
Why?
Xenograft Model Antitumor Assays
5
2019
210
0.170
Why?
DNA-Binding Proteins
2
2020
410
0.170
Why?
Glucuronidase
2
2018
47
0.160
Why?
Predictive Value of Tests
5
2009
924
0.160
Why?
Hematologic Neoplasms
2
2016
99
0.160
Why?
Proto-Oncogene Proteins c-bcl-2
2
2013
128
0.160
Why?
Cytokines
4
2007
602
0.160
Why?
Osteoclasts
4
2022
427
0.160
Why?
Syndecan-1
3
2017
73
0.160
Why?
Kaplan-Meier Estimate
6
2015
462
0.150
Why?
Healthcare Disparities
1
2022
280
0.150
Why?
Hydrocarbons, Aromatic
1
2018
2
0.150
Why?
Solvents
1
2018
29
0.150
Why?
Drug Tolerance
1
2018
59
0.150
Why?
Pyridines
1
2019
130
0.150
Why?
T-Lymphocytes, Cytotoxic
3
2010
63
0.150
Why?
Jehovah's Witnesses
1
2018
6
0.150
Why?
Dendritic Cells
3
2010
135
0.150
Why?
Vincristine
3
2003
82
0.150
Why?
Cell Differentiation
4
2022
640
0.150
Why?
Platelet Count
3
2008
65
0.140
Why?
CDC2-CDC28 Kinases
2
2015
11
0.140
Why?
Risk Assessment
5
2023
1268
0.140
Why?
Iron
2
2017
120
0.140
Why?
Occupational Diseases
1
2018
83
0.140
Why?
Interleukin-6
2
2018
261
0.140
Why?
Arsenicals
2
2010
14
0.140
Why?
Ascorbic Acid
1
2017
21
0.140
Why?
Pyruvate Kinase
1
2017
7
0.140
Why?
Oxides
2
2010
18
0.140
Why?
Mice, SCID
5
2018
171
0.140
Why?
Drug Combinations
1
2017
128
0.140
Why?
Occupational Exposure
1
2018
113
0.140
Why?
Anthropometry
1
2017
95
0.130
Why?
RNA Splicing
1
2017
38
0.130
Why?
Glycolysis
1
2017
69
0.130
Why?
Immunotherapy
4
2006
234
0.130
Why?
Transcription Factors
1
2020
561
0.130
Why?
Immunoglobulin lambda-Chains
1
2016
14
0.130
Why?
Factor V
3
2011
11
0.130
Why?
MicroRNAs
1
2020
345
0.130
Why?
Immunoglobulin kappa-Chains
1
2016
20
0.130
Why?
Fibrinolytic Agents
2
2007
125
0.130
Why?
Tumor Cells, Cultured
6
2019
453
0.130
Why?
Incidence
3
2009
1027
0.130
Why?
Leukocytes, Mononuclear
2
2014
118
0.130
Why?
Oncolytic Virotherapy
1
2015
15
0.130
Why?
Reproductive History
1
2015
4
0.130
Why?
Hormone Replacement Therapy
1
2015
33
0.120
Why?
Cyclopentanes
1
2015
10
0.120
Why?
Cell Adhesion Molecules
1
2015
86
0.120
Why?
Hemorrhage
2
2007
195
0.120
Why?
Ubiquitins
1
2015
39
0.120
Why?
NF-kappa B
3
2018
306
0.120
Why?
Cation Transport Proteins
1
2015
27
0.120
Why?
Receptors, Cell Surface
1
2015
117
0.120
Why?
Aldehyde Dehydrogenase
1
2014
25
0.120
Why?
Postmenopause
1
2015
96
0.120
Why?
Intestines
1
2016
152
0.120
Why?
Drug Monitoring
1
2015
81
0.120
Why?
Translocation, Genetic
3
2005
236
0.110
Why?
Protein-Tyrosine Kinases
1
2015
85
0.110
Why?
Leukapheresis
1
2014
17
0.110
Why?
Transplantation Chimera
3
2003
14
0.110
Why?
Myeloma Proteins
2
2020
24
0.110
Why?
Gene Deletion
3
2004
260
0.110
Why?
Antibodies
2
2024
151
0.110
Why?
Polymorphism, Single Nucleotide
1
2016
468
0.110
Why?
Receptor, Parathyroid Hormone, Type 1
1
2013
24
0.110
Why?
Veratrum Alkaloids
1
2013
5
0.110
Why?
Body Mass Index
1
2017
674
0.110
Why?
Multidrug Resistance-Associated Proteins
1
2013
16
0.110
Why?
Isoxazoles
1
2013
14
0.110
Why?
Biopsy
2
2006
588
0.110
Why?
Hedgehog Proteins
1
2013
30
0.110
Why?
Sulfones
1
2013
24
0.110
Why?
Genetic Predisposition to Disease
1
2016
507
0.110
Why?
Cystatin M
2
2024
19
0.110
Why?
Itraconazole
1
2013
41
0.110
Why?
Carrier Proteins
2
2017
297
0.100
Why?
Metaphase
3
2008
45
0.100
Why?
Intercellular Adhesion Molecule-1
1
2013
61
0.100
Why?
Wnt Proteins
1
2013
97
0.100
Why?
B-Cell Maturation Antigen
2
2024
98
0.100
Why?
Renal Insufficiency
3
2009
109
0.100
Why?
Risk
2
2011
325
0.100
Why?
Infusions, Intravenous
2
2003
212
0.100
Why?
Viremia
1
2012
21
0.100
Why?
Chromosomes, Human, Pair 11
2
2002
49
0.100
Why?
Drug Delivery Systems
2
2005
143
0.100
Why?
Cytomegalovirus Infections
1
2012
37
0.100
Why?
Radiopharmaceuticals
2
2021
202
0.100
Why?
Clinical Trials, Phase II as Topic
1
2012
46
0.100
Why?
Clinical Trials, Phase III as Topic
1
2012
47
0.100
Why?
Phosphorylation
2
2020
520
0.090
Why?
Receptors, KIR
2
2008
12
0.090
Why?
Fluorodeoxyglucose F18
2
2021
187
0.090
Why?
Medical Oncology
1
2012
97
0.090
Why?
Alcohol Drinking
1
2013
228
0.090
Why?
Inflammation
1
2016
607
0.090
Why?
Reoperation
2
2004
461
0.090
Why?
Ligands
2
2009
203
0.090
Why?
Drug Evaluation, Preclinical
1
2012
144
0.090
Why?
Age Factors
3
2005
1118
0.090
Why?
Smoking
1
2014
506
0.090
Why?
Tretinoin
2
2009
51
0.090
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
5
0.090
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
20
0.090
Why?
Recombinant Proteins
2
2010
477
0.090
Why?
Janus Kinase 1
1
2010
16
0.090
Why?
Antineoplastic Agents, Hormonal
2
2007
49
0.090
Why?
Down-Regulation
2
2010
338
0.080
Why?
Macrophages
1
2013
365
0.080
Why?
MAP Kinase Kinase 1
1
2010
23
0.080
Why?
Cyclin-Dependent Kinases
1
2010
26
0.080
Why?
Neoplasm Staging
3
2015
738
0.080
Why?
Authorship
1
2010
12
0.080
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
80
0.080
Why?
Bone Density Conservation Agents
1
2010
74
0.080
Why?
Conflict of Interest
1
2010
25
0.080
Why?
Drug Industry
1
2010
38
0.080
Why?
Disclosure
1
2010
39
0.080
Why?
Diphosphonates
1
2010
90
0.080
Why?
Mice, Transgenic
3
2021
537
0.080
Why?
Chromosome Banding
2
2006
18
0.080
Why?
Leukocyte Count
2
2014
71
0.080
Why?
Plasmacytoma
2
2011
42
0.080
Why?
Periodicals as Topic
1
2010
58
0.080
Why?
Maximum Tolerated Dose
2
2009
39
0.080
Why?
Oligonucleotide Array Sequence Analysis
5
2014
400
0.080
Why?
Cell Cycle
2
2010
227
0.080
Why?
Magnetic Resonance Imaging
3
2007
1546
0.080
Why?
Cryoglobulinemia
1
2008
13
0.080
Why?
Blotting, Western
3
2015
575
0.080
Why?
Vascular Endothelial Growth Factor A
1
2009
180
0.070
Why?
Cytogenetics
1
2008
21
0.070
Why?
Prednisone
2
2009
101
0.070
Why?
Sulfonamides
1
2009
125
0.070
Why?
Polyethylene Glycols
1
2008
84
0.070
Why?
Pulmonary Embolism
1
2009
99
0.070
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2015
568
0.070
Why?
Neutrophils
2
2014
142
0.070
Why?
Immunophenotyping
2
2007
106
0.070
Why?
Adoptive Transfer
1
2007
29
0.070
Why?
Hemoglobins
1
2008
112
0.070
Why?
Heparin, Low-Molecular-Weight
1
2007
21
0.070
Why?
CD8-Positive T-Lymphocytes
2
2024
127
0.070
Why?
Histocompatibility Antigens Class I
1
2007
46
0.070
Why?
Phlebography
1
2007
60
0.070
Why?
Fibrinolysis
1
2007
5
0.070
Why?
Blood Coagulation Factors
1
2007
17
0.070
Why?
Ammonia
1
2007
78
0.070
Why?
Serum Albumin
2
2008
57
0.070
Why?
Chi-Square Distribution
1
2007
275
0.070
Why?
Biomedical Research
1
2010
243
0.070
Why?
Brain
2
2007
1318
0.070
Why?
Cell Membrane
1
2007
247
0.070
Why?
Drug Administration Schedule
2
2006
373
0.070
Why?
Osteoprotegerin
1
2006
52
0.070
Why?
Models, Genetic
1
2006
166
0.060
Why?
Guanosine
1
2006
5
0.060
Why?
Antibiotics, Antineoplastic
1
2006
77
0.060
Why?
Sex Factors
3
2016
718
0.060
Why?
Renal Dialysis
1
2007
171
0.060
Why?
Femur Head Necrosis
1
2005
18
0.060
Why?
Neovascularization, Physiologic
1
2005
68
0.060
Why?
Survivors
1
2006
126
0.060
Why?
Karyotyping
1
2005
65
0.060
Why?
Guanosine Triphosphate
1
2004
20
0.060
Why?
Gene Duplication
1
2005
14
0.060
Why?
Oncogene Proteins, Fusion
1
2005
57
0.060
Why?
Tissue Donors
2
2003
121
0.060
Why?
Kidney Transplantation
1
2007
189
0.060
Why?
Proteolysis
2
2015
96
0.060
Why?
Thrombophlebitis
1
2004
24
0.060
Why?
Genomic Instability
1
2005
90
0.060
Why?
Tomography, Emission-Computed
1
2004
53
0.060
Why?
Ferritins
1
2024
30
0.050
Why?
RNA Interference
2
2015
179
0.050
Why?
Myeloid Progenitor Cells
1
2023
17
0.050
Why?
X-Ray Microtomography
1
2024
78
0.050
Why?
Chromatography, High Pressure Liquid
1
2004
326
0.050
Why?
Patient Selection
1
2005
257
0.050
Why?
Stem Cell Factor
1
2003
7
0.050
Why?
Discitis
1
2003
11
0.050
Why?
Confidence Intervals
1
2003
155
0.050
Why?
Neoplastic Cells, Circulating
1
2004
74
0.050
Why?
Probability
1
2003
163
0.050
Why?
Lymphocyte Transfusion
1
2003
12
0.050
Why?
Anxiety
1
2005
285
0.050
Why?
Interferons
1
2002
38
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Cell Count
1
2003
150
0.050
Why?
Cyclosporine
1
2003
67
0.050
Why?
Drug Therapy, Combination
2
2017
387
0.050
Why?
Geography
1
2022
60
0.050
Why?
Tacrolimus
1
2003
54
0.050
Why?
Thyroid Function Tests
1
2002
25
0.050
Why?
Blood Group Incompatibility
1
2002
5
0.050
Why?
Stromal Cells
1
2002
75
0.050
Why?
Administration, Oral
1
2003
438
0.050
Why?
ABO Blood-Group System
1
2002
15
0.050
Why?
Thyrotropin
1
2002
49
0.050
Why?
Leukemia, Promyelocytic, Acute
1
2002
11
0.050
Why?
Drug Interactions
1
2002
207
0.050
Why?
Genomics
1
2023
238
0.050
Why?
Fatal Outcome
1
2002
197
0.050
Why?
Cell Division
1
2002
292
0.050
Why?
Chromosome Mapping
3
2006
143
0.050
Why?
Cells, Cultured
1
2005
1563
0.050
Why?
Graft Survival
1
2002
160
0.050
Why?
Acute Disease
1
2002
374
0.050
Why?
RANK Ligand
1
2022
186
0.050
Why?
Cluster Analysis
3
2006
209
0.040
Why?
Young Adult
3
2015
4075
0.040
Why?
Tomography, X-Ray Computed
1
2006
1163
0.040
Why?
Depression
1
2005
577
0.040
Why?
Neoplasm Transplantation
1
2020
83
0.040
Why?
Odds Ratio
2
2016
550
0.040
Why?
Pain
1
2003
386
0.040
Why?
3' Untranslated Regions
1
2020
52
0.040
Why?
Staphylococcal Infections
1
2003
267
0.040
Why?
Positron-Emission Tomography
1
2021
290
0.040
Why?
Postoperative Complications
1
2007
1030
0.040
Why?
Crystallography, X-Ray
1
2019
145
0.040
Why?
Antigens, CD
2
2015
221
0.040
Why?
Protein Conformation
1
2019
163
0.040
Why?
Mice, Nude
1
2019
247
0.040
Why?
Mice, Inbred BALB C
1
2019
293
0.040
Why?
Coculture Techniques
2
2012
140
0.040
Why?
Bone Marrow Cells
2
2015
195
0.040
Why?
Receptors, Interleukin-6
1
2018
22
0.040
Why?
Antigens, CD19
1
2018
28
0.040
Why?
Microarray Analysis
1
2018
69
0.040
Why?
Drug Resistance
1
2018
65
0.040
Why?
Disease Management
1
2020
179
0.040
Why?
Interferon-gamma
2
2010
175
0.040
Why?
Protein Stability
1
2018
42
0.040
Why?
Gene Knockdown Techniques
1
2018
104
0.040
Why?
Epidemiologic Methods
2
2008
47
0.030
Why?
Aerobiosis
1
2017
13
0.030
Why?
Cross-Sectional Studies
1
2022
1601
0.030
Why?
Microfilament Proteins
1
2017
42
0.030
Why?
HLA-A Antigens
2
2007
10
0.030
Why?
Thyroid Hormones
1
2017
20
0.030
Why?
Calcium-Binding Proteins
1
2017
55
0.030
Why?
Transplantation, Heterologous
1
2017
73
0.030
Why?
Vaccination
2
2010
275
0.030
Why?
Polycomb Repressive Complex 1
1
2016
3
0.030
Why?
Transmembrane Activator and CAML Interactor Protein
1
2016
6
0.030
Why?
Proto-Oncogene Proteins c-myc
1
2017
50
0.030
Why?
Genetic Loci
1
2016
45
0.030
Why?
Protein Binding
1
2018
648
0.030
Why?
Antibodies, Neoplasm
2
2006
28
0.030
Why?
Mice, Inbred ICR
1
2016
22
0.030
Why?
Mice, Knockout
1
2018
840
0.030
Why?
Microscopy, Electron, Transmission
1
2015
73
0.030
Why?
Genome-Wide Association Study
1
2016
163
0.030
Why?
Reoviridae
1
2015
25
0.030
Why?
Tumor Burden
1
2016
130
0.030
Why?
ras Proteins
1
2015
65
0.030
Why?
RNA, Messenger
2
2010
1085
0.030
Why?
Repressor Proteins
1
2016
149
0.030
Why?
Receptors, Transferrin
1
2015
16
0.030
Why?
Disease Models, Animal
2
2013
1431
0.030
Why?
Side-Population Cells
1
2015
3
0.030
Why?
Models, Biological
1
2018
717
0.030
Why?
Lentivirus
1
2015
17
0.030
Why?
Retinal Dehydrogenase
1
2014
10
0.030
Why?
Adenine
1
2015
30
0.030
Why?
Family
1
2016
175
0.030
Why?
Molecular Targeted Therapy
1
2016
122
0.030
Why?
Reactive Oxygen Species
1
2017
408
0.030
Why?
Cyclin B
1
2014
5
0.030
Why?
G2 Phase Cell Cycle Checkpoints
1
2014
9
0.030
Why?
CDC2 Protein Kinase
1
2014
17
0.030
Why?
Portraits as Topic
1
2014
2
0.030
Why?
Cell Lineage
1
2014
83
0.030
Why?
Drug Synergism
1
2014
149
0.030
Why?
Mitosis
1
2014
87
0.030
Why?
beta Catenin
1
2015
96
0.030
Why?
Piperidines
1
2015
97
0.030
Why?
Drug Screening Assays, Antitumor
1
2014
129
0.030
Why?
Pyrazoles
1
2015
111
0.030
Why?
Cell Movement
1
2015
244
0.030
Why?
Proportional Hazards Models
2
2006
416
0.030
Why?
Patient Safety
1
2014
102
0.030
Why?
Peptide Library
1
2013
16
0.030
Why?
Adolescent
2
2014
6453
0.030
Why?
Receptors, IgG
1
2013
23
0.030
Why?
Epitopes
1
2013
60
0.030
Why?
Chromosomal Instability
1
2013
16
0.030
Why?
Membrane Glycoproteins
2
2006
246
0.030
Why?
Protein Kinase Inhibitors
1
2014
204
0.030
Why?
Antibodies, Monoclonal, Murine-Derived
1
2012
44
0.020
Why?
Immunoglobulin M
1
2012
58
0.020
Why?
Interleukin Receptor Common gamma Subunit
1
2012
8
0.020
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
9
0.020
Why?
Cytomegalovirus
1
2012
28
0.020
Why?
Viral Load
1
2012
76
0.020
Why?
Peripheral Nervous System Diseases
1
2012
57
0.020
Why?
Interleukin-2
1
2012
70
0.020
Why?
Virus Activation
1
2012
37
0.020
Why?
Arkansas
2
2008
1974
0.020
Why?
Immunoenzyme Techniques
1
2012
140
0.020
Why?
Viper Venoms
1
2011
7
0.020
Why?
Asymptomatic Diseases
1
2011
38
0.020
Why?
Lymphocyte Activation
1
2012
169
0.020
Why?
Protein C
1
2011
18
0.020
Why?
Neoadjuvant Therapy
1
2012
119
0.020
Why?
Chemotherapy, Adjuvant
1
2011
119
0.020
Why?
Interferon Regulatory Factor-1
1
2010
14
0.020
Why?
Cell Growth Processes
1
2010
22
0.020
Why?
Antiviral Agents
1
2012
171
0.020
Why?
Immunoglobulin Idiotypes
1
2010
5
0.020
Why?
CD40 Ligand
1
2010
14
0.020
Why?
Hypersensitivity, Delayed
1
2010
18
0.020
Why?
Interleukin-4
1
2010
42
0.020
Why?
Immunity, Cellular
1
2010
68
0.020
Why?
Adjuvants, Immunologic
1
2010
52
0.020
Why?
Diagnosis, Differential
2
2004
1029
0.020
Why?
Mutation
1
2015
1275
0.020
Why?
RNA, Small Interfering
1
2010
208
0.020
Why?
Physician's Role
1
2010
47
0.020
Why?
Education, Medical, Continuing
1
2010
70
0.020
Why?
Practice Guidelines as Topic
1
2012
473
0.020
Why?
Hyperhomocysteinemia
1
2009
30
0.020
Why?
Protein Isoforms
1
2009
116
0.020
Why?
Indazoles
1
2009
46
0.020
Why?
Cytotoxicity Tests, Immunologic
1
2008
26
0.020
Why?
Algorithms
1
2012
624
0.020
Why?
Safety
1
2009
77
0.020
Why?
Vasculitis
1
2008
29
0.020
Why?
Haplotypes
1
2008
83
0.020
Why?
Ploidies
1
2008
11
0.020
Why?
Twins
1
2007
20
0.020
Why?
Double-Blind Method
1
2009
710
0.020
Why?
Age Distribution
1
2007
172
0.020
Why?
C-Reactive Protein
1
2008
145
0.020
Why?
Creatinine
1
2007
142
0.020
Why?
Multigene Family
1
2006
46
0.020
Why?
Blood Proteins
1
2007
83
0.020
Why?
Partial Thromboplastin Time
1
2006
12
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
35
0.020
Why?
Heterozygote
1
2006
83
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
RNA, Neoplasm
1
2006
44
0.020
Why?
Proteoglycans
1
2006
81
0.020
Why?
Amiloride
1
2005
8
0.020
Why?
HLA-A2 Antigen
1
2005
11
0.020
Why?
Cell Line
1
2008
997
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
180
0.020
Why?
Transduction, Genetic
1
2005
45
0.020
Why?
Radiography
1
2007
482
0.020
Why?
Data Interpretation, Statistical
1
2006
162
0.020
Why?
Neoplasms, Experimental
1
2006
111
0.020
Why?
Sensitivity and Specificity
1
2007
855
0.010
Why?
Interferon-alpha
1
2005
48
0.010
Why?
Monocytes
1
2005
130
0.010
Why?
Databases, Factual
1
2007
676
0.010
Why?
Clone Cells
1
2004
72
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2005
224
0.010
Why?
Monosomy
1
2003
5
0.010
Why?
Fibroblasts
1
2005
338
0.010
Why?
Trisomy
1
2003
27
0.010
Why?
History, 21st Century
1
2003
57
0.010
Why?
History, 20th Century
1
2003
100
0.010
Why?
Interphase
1
2003
12
0.010
Why?
Plasmapheresis
1
2003
11
0.010
Why?
Back Pain
1
2003
38
0.010
Why?
United States
1
2013
5005
0.010
Why?
Pore Forming Cytotoxic Proteins
1
2002
9
0.010
Why?
Perforin
1
2002
11
0.010
Why?
Cohort Studies
1
2006
1451
0.010
Why?
Anemia
1
2003
67
0.010
Why?
Antigen Presentation
1
2002
25
0.010
Why?
Red-Cell Aplasia, Pure
1
2002
7
0.010
Why?
Prevalence
1
2005
967
0.010
Why?
Quality Assurance, Health Care
1
2003
149
0.010
Why?
Erythrocyte Transfusion
1
2002
52
0.010
Why?
Cell Culture Techniques
1
2002
97
0.010
Why?
DNA, Neoplasm
1
2002
144
0.010
Why?
Graft Rejection
1
2002
173
0.010
Why?
Kidney Diseases
1
2003
213
0.010
Why?
Anti-Bacterial Agents
1
2003
751
0.010
Why?
Tricot's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description